Key Details
Price
$0.86PE Ratio
10.75Annual ROE
24.95%Beta
0.65Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 13, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 30, 25 HC Wainwright & Co.
BuyDec 20, 24 Evercore ISI Group
In-LineDec 2, 24 HC Wainwright & Co.
BuyNov 18, 24 TD Cowen
HoldNov 15, 24 Cantor Fitzgerald
OverweightNov 4, 24 HC Wainwright & Co.
BuyOct 3, 24 HC Wainwright & Co.
BuyAug 6, 24 TD Cowen
BuyAug 6, 24 HC Wainwright & Co.
BuyAug 6, 24 Cantor Fitzgerald
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Spero Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Spero Therapeutics?
- Does Spero Therapeutics pay dividends?
- What sector is Spero Therapeutics in?
- What industry is Spero Therapeutics in?
- What country is Spero Therapeutics based in?
- When did Spero Therapeutics go public?
- Is Spero Therapeutics in the S&P 500?
- Is Spero Therapeutics in the NASDAQ 100?
- Is Spero Therapeutics in the Dow Jones?
- When was Spero Therapeutics's last earnings report?
- When does Spero Therapeutics report earnings?
- Should I buy Spero Therapeutics stock now?
What is the ticker symbol for Spero Therapeutics?
The ticker symbol for Spero Therapeutics is NASDAQ:SPRO
Does Spero Therapeutics pay dividends?
No, Spero Therapeutics does not pay dividends
What sector is Spero Therapeutics in?
Spero Therapeutics is in the Healthcare sector
What industry is Spero Therapeutics in?
Spero Therapeutics is in the Biotechnology industry
What country is Spero Therapeutics based in?
Spero Therapeutics is headquartered in United States
When did Spero Therapeutics go public?
Spero Therapeutics's initial public offering (IPO) was on November 2, 2017
Is Spero Therapeutics in the S&P 500?
No, Spero Therapeutics is not included in the S&P 500 index
Is Spero Therapeutics in the NASDAQ 100?
No, Spero Therapeutics is not included in the NASDAQ 100 index
Is Spero Therapeutics in the Dow Jones?
No, Spero Therapeutics is not included in the Dow Jones index
When was Spero Therapeutics's last earnings report?
Spero Therapeutics's most recent earnings report was on Nov 14, 2024
When does Spero Therapeutics report earnings?
The next expected earnings date for Spero Therapeutics is Mar 13, 2025
Should I buy Spero Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions